ContextVision presents Annual Report 2021

Annual reports, ContextVision, Digital Pathology, Home, Investor News, News 2022-03-31
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: For inquiries, please contact CFO Markus Hökerberg E-mail: ### About ContextVision ContextVision is a medical technology software company […]
Read More

ContextVision shows strong momentum in Q4, leading to record sales for the year

ContextVision, Financial reports, Home, Investor News, News 2022-02-17
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK (94.7), which is the highest revenue in the history of the company. After a slow […]
Read More

Progress in establishing reference centers within digital pathology

ContextVision, Financial reports, Home, Investor News, News 2021-04-22
ContextVision today reports its first quarter results for 2021. The quarter saw strong and promising progress within digital pathology and the company’s first product, INIFY Prostate Screening. While the ongoing pandemic slowed sales slightly, solid financials – paired with close dialogues with present and prospective clients – provide a positive outlook.
Read More

ContextVision presents Annual Report 2020 and Remuneration Report 2020

Annual reports, ContextVision, Financial reports, Home, Investor News, News 2021-04-07
STOCKHOLM – April 7, 2021 – Please find ContextVision’s Annual Report 2020 and Remuneration Report 2020 attached. The reports can also be found on the company’s website: www.contextvision.se Printed copies of the reports will be distributed upon request by e-mail: For inquiries, please contact CFO Ann-Charlotte Linderoth E-mail:   About ContextVision ContextVision is […]
Read More

ContextVision’s second quarter sees multiple product releases including digital pathology debut

Financial reports, Investor News, News 2020-08-13
ContextVision today reports a progressive second quarter. INIFY® Prostate Screening – the company’s first decision support tool in a planned digital pathology portfolio – was granted CE-mark status, paving the way for a strong entry into the fast-growing digital pathology market. In addition, the company continues to spearhead the image enhancement market with its new next-generation ultrasound product, Rivent®.
Read More